LILRB2 and gastric cancer: On the other hand, Murdaca et al. reported that they found no significant correlation between the expression of HLA-G and other clinicopathological variables such as sex, age, stage, grade, histotype26, but Yan et al. reported a worse OS in patients whose tumors had high HLA-G expression and a poor clinical outcome among women with GC expressing HLA-G and ILT-4.